Larimar Therapeutics
Larimar Therapeutics
Categories
Biotechnology
About
Chondrial Therapeutics, LLC was formed to discover and develop orphan drugs for mitochondrial diseases. Our proprietary protein replacement platform is initially targeted at Friedreich's Ataxia, a disease afflicting more 15,000 people in the US and Europe. Our goal is to restore normal life to individuals with mitochondrial diseases. Our passion for solutions is only matched by our sense of urgency.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.